The pixel promised discretion. The FTC read the payload
Any healthcare marketing company should read the Hims and Hers FTC suit as a warning: audit what tracking pixels see before a regulator reads it for you.
The patch had no GLP-1. The copy is what went to court
Weight loss claims put a patch brand in a US federal court this month. Five honest checks for healthcare marketers before the ad copy becomes the liability.
U.S. News and the quiet arrival of a GLP-1 telehealth referee
U.S. News just launched its first GLP-1 telehealth ratings. See why semaglutide online searches are surging, the six pillars, and what it means for trust.
Snap built a door for the fine print, and pharma walked through it
Snap’s multi-CTA unit lets pharma advertising carry safety disclosure inside the feed. Five honest wins before the FDA closes the adequate provision gap.
The $262m headline that points the wrong way
Hims and Hers spent $262m on marketing last quarter, yet its healthcare marketing strategy got cheaper. Five honest rules for reading the ratio, not the total.
The waitlist was the advertisement all along
Weight loss advertising starts at the waitlist. The MHRA named 13 companies on 5 August 2026, and three of six decisions hit emails, texts and sign-up pages.
The cheque was $15. The cost was the whole measurement stack
Five US health systems settled Meta Pixel class actions. The cash is trivial; the remedy is not, and one has switched off analytics and adtech for two years.
The regulator called your funnel a health record
The Dutch privacy regulator says intimate app data reaches advertisers. Five digital health marketing lessons on consent, special category data and risk.
The pixel is now the liability
The FTC sued a telehealth brand over ad pixels and the ASA banned two weight-loss ads. Five real risks every healthcare marketing team now carries in its stack.